Ciprofloxacin vs Ceftazidime for Empirical Treatment of High-Risk Neutropenic Fever in Children With Hematologic Malignancies

NCT07016165 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Neutropenic Fever
Acute Lymphoblastic Leukemia
Acute Myeloblastic Leukemia
Non Hodgkin Lymphoma

Interventions

DRUG: Ceftazidime
DRUG: Ciprofloxacin

Sponsor

Gadjah Mada University